FACTIVE Side Effects

5700838-4 | Stevens-johnson Syndrome
on Mar 27, 2008 Male patient from MEXICO , 36 years of age, weighting 154.3 lb, was diagnosed with respiratory tract infection and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. Factive dosage: 320 Mg, Qd, Oral. Patient was hospitalized.

5699802-3 | Heart Rate Increased, Respiratory Rate Increased
Patient was taking Factive (View Usage). Patient had the following side effects: heart rate increased, respiratory rate increased on Mar 25, 2008 from UNITED STATES Additional patient health information: Female patient , 29 years of age, weighting 119.9 lb, was diagnosed with bronchopneumonia and. Factive dosage: 320 Mg, Qd, Oral. Patient was hospitalized.

5676770-1 | Rash Macular, Skin Exfoliation
Adverse event was reported on Mar 05, 2008 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with bronchopneumonia and. Location: UNITED STATES , 29 years of age, After Factive was administered, patient had the following side effects: rash macular, skin exfoliation. Patient was hospitalized.

5642247-2 | Alanine Aminotransferase Increased, Anorexia, Asthenia, Blood Chloride Decreased, Blood Glucose Increased, Dysstasia, Faecal Incontinence, Fatigue
on Feb 12, 2008 Male patient from UNITED STATES , 38 years of age, weighting 229.9 lb, was diagnosed with pneumonia (What is pneumonia?), influenza immunisation and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, anorexia, asthenia, blood chloride decreased, blood glucose increased, dysstasia, faecal incontinence, fatigue. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with FLUVAX (0.5 Ml, Intramuscular) (View Fluvax Review and Fluvax Label ), CRESTOR (View Crestor Review and Crestor Label ), IMITREX (View Imitrex Review and Imitrex Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SYMBICORT 160 4.5 (BUDESONIDE, FORMOTEROL FUMARATE) (View Symbicort 160-4.5 (budesonide, Formoterol Fumarate) Review and Symbicort 160-4.5 (budesonide, Formoterol Fumarate) Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ). Patient was hospitalized.


5641085-4 | Hallucination, Hypoxia, Incoherent, Loss Of Consciousness
on Feb 11, 2008 Male patient from MEXICO , 83 years of age, weighting 154.3 lb, was diagnosed with bronchitis (What is bronchitis?), pneumonia (What is pneumonia?) and was treated with Factive (View Usage). Patient had the following side effects: hallucination, hypoxia, incoherent, loss of consciousness. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMBROXOL (AMBROXOL) (View Ambroxol (ambroxol) Review and Ambroxol (ambroxol) Label ), SYMBICORT (BUDESONIDE, FORMOTEROL FUMARATE) INHALER (View Symbicort (budesonide, Formoterol Fumarate) Inhaler Review and Symbicort (budesonide, Formoterol Fumarate) Inhaler Label ).

5630025-X | Hallucination, Hypoxia, Incoherent, Loss Of Consciousness, Pneumonia
Patient was taking Factive (View Usage). After Factive was administered, patient had the following side effects: hallucination, hypoxia, incoherent, loss of consciousness, pneumonia (What is pneumonia?) on Feb 06, 2008 from MEXICO Additional patient health information: Male patient , 83 years of age, weighting 154.3 lb, was diagnosed with bronchitis (What is bronchitis?) and. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), AMBROXOL (AMBROXOL) (View Ambroxol (ambroxol) Review and Ambroxol (ambroxol) Label ).

5627161-0 | Anaphylactic Reaction
Adverse event was reported on Feb 13, 2008 by a Female patient taking Factive (View Usage) (Dosage: 1 Tablet Once Per Day Po) was diagnosed with sinusitis (What is sinusitis?) and. Location: UNITED STATES , 49 years of age, weighting 260.0 lb, Patient experienced the following unwanted or unexpected effects: anaphylactic reaction.

5623833-2 | Alanine Aminotransferase Increased, Anorexia, Asthenia, Blood Chloride Decreased, Blood Glucose Increased, Dysstasia, Faecal Incontinence, Fatigue
on Jan 24, 2008 Male patient from UNITED STATES , 38 years of age, weighting 229.9 lb, was diagnosed with lobar pneumonia, influenza immunisation and was treated with Factive (View Usage). Patient had the following side effects: alanine aminotransferase increased, anorexia, asthenia, blood chloride decreased, blood glucose increased, dysstasia, faecal incontinence, fatigue. Factive dosage: 320 Mg,qd; Oral. During the same period patient was treated with FLUVAX (0.5 Ml, Intramuscular) (View Fluvax Review and Fluvax Label ), CRESTOR (View Crestor Review and Crestor Label ), IMITREX (View Imitrex Review and Imitrex Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), ZITHROMAX (View Zithromax Review and Zithromax Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SYMBICORT 160 4.5 (BUDESONIDE, FORMOTEROL FUMARATE) (View Symbicort 160-4.5 (budesonide, Formoterol Fumarate) Review and Symbicort 160-4.5 (budesonide, Formoterol Fumarate) Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ). Patient was hospitalized.

5615248-8 | Alanine Aminotransferase Increased, Anaphylactic Shock, Face Oedema, Heart Rate Increased, Neutrophilia, Rash
on Jan 25, 2008 Female patient from MEXICO , 48 years of age, weighting 143.3 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: alanine aminotransferase increased, anaphylactic shock, face oedema, heart rate increased, neutrophilia, rash (What is rash?). Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with DESLORATADINE (DESLORATADINE) (View Desloratadine (desloratadine) Review and Desloratadine (desloratadine) Label ).

5604409-X | Anaphylactic Shock, Loss Of Consciousness, Respiratory Arrest
Patient was taking Factive (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic shock, loss of consciousness, respiratory arrest on Jan 23, 2008 from UNITED STATES Additional patient health information: Female patient , 71 years of age, weighting 130.0 lb, was diagnosed with bronchitis (What is bronchitis?) and. Factive dosage: 1 Tablet Daily Po (duration: Only 1 Tablet Was Taken). Patient was hospitalized.

5599584-X | Alanine Aminotransferase Increased, Atelectasis, Blood Alkaline Phosphatase Increased, Chills, Erythema Multiforme, Nausea, Pain, Pulmonary Congestion, Pyrexia
Adverse event was reported on Jan 03, 2008 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with pneumonia (What is pneumonia?) and. Location: UNITED STATES , 40 years of age, weighting 170.0 lb, Patient had the following side effects: alanine aminotransferase increased, atelectasis, blood alkaline phosphatase increased, chills, erythema multiforme, nausea (What is nausea?), pain (What is pain?), pulmonary congestion, pyrexia. Patient was hospitalized.

5589457-0 | Rash
on Jan 10, 2008 Female patient from UNITED STATES , 55 years of age, weighting 160.0 lb, was diagnosed with bronchitis (What is bronchitis?), sinusitis (What is sinusitis?) and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: rash (What is rash?). Factive dosage: .

5578911-3 | Constipation, Dyspepsia, Dysphonia, Stevens-johnson Syndrome, Tongue Blistering, Upper Respiratory Tract Infection
on Dec 12, 2007 Female patient from UNITED STATES , 49 years of age, was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: constipation (What is constipation?), dyspepsia, dysphonia, stevens-johnson syndrome, tongue blistering, upper respiratory tract infection. Factive dosage: . During the same period patient was treated with SYNTHROID (View Synthroid Review and Synthroid Label ), NADOLOL (View Nadolol Review and Nadolol Label ), ATIVAN (View Ativan Review and Ativan Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5546363-5 | Dyspnoea, Rash Macular, Skin Burning Sensation
Patient was taking Factive (View Usage). Patient had the following side effects: dyspnoea, rash macular, skin burning sensation on Dec 06, 2007 from UNITED STATES Additional patient health information: Female patient , weighting 151.0 lb, was diagnosed with pneumonia (What is pneumonia?) and. Factive dosage: 1 Tablet Once A Day Po. Patient was hospitalized.

5543115-7 | Guillain-barre Syndrome, Nervous System Disorder
Adverse event was reported on Nov 21, 2007 by a Male patient taking Factive (View Usage) (Dosage: 320 Mg Qd) was diagnosed with pneumonia (What is pneumonia?) and. Location: UNITED STATES , 45 years of age, After Factive was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?), nervous system disorder. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), IMITREX (View Imitrex Review and Imitrex Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

5535780-5 | Blood Glucose Decreased
on Nov 19, 2007 Male patient from UNITED STATES , 79 years of age, was diagnosed with pneumonia (What is pneumonia?) and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: blood glucose decreased. Factive dosage: 320 Mg, Oral. During the same period patient was treated with CEFTRIAXONE (View Ceftriaxone Review and Ceftriaxone Label ), GLYBURIDE (GLIBENCLAMIDE, METFORMIN HYDROCHLORIDE) (View Glyburide (glibenclamide, Metformin Hydrochloride) Review and Glyburide (glibenclamide, Metformin Hydrochloride) Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), TAMSULOSIN HCL (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CLOPIDOGREL (View Clopidogrel Review and Clopidogrel Label ). Patient was hospitalized.

5532361-4 | Beta Haemolytic Streptococcal Infection, Blood Sodium Decreased, Culture Urine Positive, Ectropion, Neutrophil Percentage Increased, Psychotic Disorder, Toxic Shock Syndrome Streptococcal
on Nov 19, 2007 Female patient from UNITED STATES , 31 years of age, was diagnosed with bronchitis (What is bronchitis?) and was treated with Factive (View Usage). Patient had the following side effects: beta haemolytic streptococcal infection, blood sodium decreased, culture urine positive, ectropion, neutrophil percentage increased, psychotic disorder (What is psychotic disorder?), toxic shock syndrome streptococcal. Factive dosage: 320 Mg, Qd. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ), MULTIVITAMIN (View Multivitamin Review and Multivitamin Label ). Patient was hospitalized.

5525057-6 | Guillain-barre Syndrome
Patient was taking Factive (View Usage). After Factive was administered, patient had the following side effects: guillain-barre syndrome (What is guillain-barre syndrome?) on Nov 06, 2007 from UNITED STATES Additional patient health information: Male patient , 45 years of age, was diagnosed with pneumonia (What is pneumonia?) and. Factive dosage: 320 Mg, Qd. During the same period patient was treated with CRESTOR (View Crestor Review and Crestor Label ), IMITREX (View Imitrex Review and Imitrex Label ), LEVAQUIN (View Levaquin Review and Levaquin Label ), AZITHROMYCIN (View Azithromycin Review and Azithromycin Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ), SYMBICORT (View Symbicort Review and Symbicort Label ). Patient was hospitalized.

5523105-0 | Stevens-johnson Syndrome
Adverse event was reported on Nov 01, 2007 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd) was diagnosed with bronchitis (What is bronchitis?) and. Location: UNITED STATES , 31 years of age, Patient experienced the following unwanted or unexpected effects: stevens-johnson syndrome. During the same period patient was treated with ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), IBUPROFEN (View Ibuprofen Review and Ibuprofen Label ). Patient was hospitalized.

5487929-0 | Pyrexia, Rash Papular
on Oct 12, 2007 Male patient from UNITED STATES , weighting 248.0 lb, was diagnosed with infection (What is infection?), pulmonary congestion and was treated with Factive (View Usage). Patient had the following side effects: pyrexia, rash papular. Factive dosage: 1 Tablet Daily Po.

5472374-4 | Catheter Related Infection, Convulsion, Depressed Level Of Consciousness, Hallucination, Incoherent, Movement Disorder, Renal Failure Acute, Sinusitis, Thirst
on Sep 13, 2007 Female patient from UNITED STATES , 48 years of age, was diagnosed with urinary tract infection (What is urinary tract infection?) and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: catheter related infection, convulsion, depressed level of consciousness, hallucination, incoherent, movement disorder (What is movement disorder?), renal failure acute, sinusitis (What is sinusitis?), thirst. Factive dosage: Qd, Oral. During the same period patient was treated with HYDROCORTISONE (View Hydrocortisone Review and Hydrocortisone Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), BYETTA (View Byetta Review and Byetta Label ), MORPHINE (View Morphine Review and Morphine Label ). Patient was hospitalized.

5452084-X | Rash Pruritic
Patient was taking Factive (View Usage). Patient experienced the following unwanted or unexpected effects: rash pruritic on May 09, 2007 from UNITED STATES Additional patient health information: Female patient , 35 years of age, weighting 153.9 lb, was diagnosed with respiratory disorder and. Factive dosage: 320 Mg. Patient was hospitalized.

5403393-1 | Acarodermatitis
Adverse event was reported on Jul 13, 2007 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd) was diagnosed with bronchitis (What is bronchitis?) and. Location: JORDAN , 25 years of age, Patient had the following side effects: acarodermatitis. Patient was hospitalized.

5346902-3 | Pyrexia
on Jan 11, 2007 Female patient from UNITED STATES , 28 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: pyrexia. Factive dosage: 320 Mg, Qd, Oral. Patient was hospitalized.

5336354-1 | Erythema Multiforme, Hearing Impaired, Hypoacusis, Local Swelling, Pain Of Skin, Pharyngeal Oedema, Pruritus
on Apr 18, 2007 Female patient from UNITED STATES , 60 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: erythema multiforme, hearing impaired, hypoacusis, local swelling, pain of skin, pharyngeal oedema, pruritus. Factive dosage: Oral. During the same period patient was treated with MULTIVITAMIN (ASCORBID ACID, ERGOCALCIFEROL, FOLIC ACID, NICOTINAMIDE, (View Multivitamin (ascorbid Acid, Ergocalciferol, Folic Acid, Nicotinamide, Review and Multivitamin (ascorbid Acid, Ergocalciferol, Folic Acid, Nicotinamide, Label ), ESTRATEST (View Estratest Review and Estratest Label ), ZELNORM (View Zelnorm Review and Zelnorm Label ), CITRICAL (CALCIUM CARBONATE) (View Citrical (calcium Carbonate) Review and Citrical (calcium Carbonate) Label ), ASPIRIN (View Aspirin Review and Aspirin Label ).

5318580-0 | Rash
Patient was taking Factive (View Usage). Patient had the following side effects: rash (What is rash?) on Nov 21, 2006 from UNITED STATES Additional patient health information: Female patient , 55 years of age, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral. Patient was hospitalized.

5287916-1 | Eye Swelling, Pruritus, Throat Irritation, Tongue Disorder, Urticaria
Adverse event was reported on Apr 03, 2007 by a Female patient taking Factive (View Usage) (Dosage: 1 320 Mg Tablet Once A Day Po) was diagnosed with influenza like illness, upper respiratory tract infection and. Location: UNITED STATES , 40 years of age, weighting 150.0 lb, After Factive was administered, patient had the following side effects: eye swelling, pruritus, throat irritation, tongue disorder, urticaria. Patient was hospitalized.

5273206-X | Disorientation, Dyspnoea, Feeling Cold, Hypersensitivity, Malaise, Panic Reaction, Vomiting
on Mar 05, 2007 Male patient from UNITED STATES , 42 years of age, weighting 250.0 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: disorientation, dyspnoea, feeling cold, hypersensitivity, malaise, panic reaction, vomiting. Factive dosage: 320 Mg, Qd, Oral.

5259640-2 | Asthenia, Blister, Chills, Disorientation, Dyspnoea, Erythema, Hypoaesthesia, Hypoaesthesia Oral, Pruritus
on Mar 07, 2007 Male patient from UNITED STATES , weighting 250.0 lb, was diagnosed with ear infection (What is ear infection?) and was treated with Factive (View Usage). Patient had the following side effects: asthenia, blister, chills, disorientation, dyspnoea, erythema, hypoaesthesia, hypoaesthesia oral, pruritus. Factive dosage: 5 Day Once A Day Po One Dose. Patient was hospitalized.

5234164-7 | Chest Discomfort, Eye Swelling, Oral Pruritus, Swelling Face, Throat Irritation
Patient was taking Factive (View Usage). After Factive was administered, patient had the following side effects: chest discomfort, eye swelling, oral pruritus, swelling face, throat irritation on Jan 25, 2007 from UNITED STATES Additional patient health information: Female patient , 40 years of age, weighting 145.1 lb, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with DESLORATADINE (View Desloratadine Review and Desloratadine Label ).

5224548-5 | Blister, Burning Sensation, Lethargy, Nausea, Scab, Skin Exfoliation
Adverse event was reported on Jan 12, 2007 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with respiratory tract infection bacterial and. Location: UNITED STATES , 43 years of age, weighting 200.0 lb, Patient experienced the following unwanted or unexpected effects: blister, burning sensation, lethargy, nausea (What is nausea?), scab (What is scab?), skin exfoliation. Patient was hospitalized.

5221685-6 | Abdominal Pain, Asthenia, Body Temperature Increased, Diarrhoea, Dyspepsia, Flushing, Heart Rate Increased, Impaired Driving Ability, Impaired Work Ability
on Jan 26, 2007 Female patient from UNITED STATES , 59 years of age, weighting 135.0 lb, was diagnosed with bronchitis (What is bronchitis?) and was treated with Factive (View Usage). Patient had the following side effects: abdominal pain (What is abdominal pain?), asthenia, body temperature increased, diarrhoea, dyspepsia, flushing, heart rate increased, impaired driving ability, impaired work ability. Factive dosage: One Tablet Daily. During the same period patient was treated with STERIOD SHOT. MEDENT. (View Steriod Shot. Medent. Review and Steriod Shot. Medent. Label ).

5210160-0 | Periorbital Oedema
on Jul 31, 2006 Female patient from UNITED STATES , 65 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: periorbital oedema. Factive dosage: .

5210157-0 | Dizziness, Hypotension
Patient was taking Factive (View Usage). Patient experienced the following unwanted or unexpected effects: dizziness (What is dizziness?), hypotension on Jul 20, 2006 from UNITED STATES Additional patient health information: Male patient , 82 years of age, weighting 149.9 lb, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ).

5210156-9 | Face Oedema, Oedema Peripheral, Rash Macular
Adverse event was reported on Jul 18, 2006 by a Male patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with respiratory tract infection bacterial and. Location: UNITED STATES , 55 years of age, weighting 164.0 lb, Patient had the following side effects: face oedema, oedema peripheral, rash macular.

5210155-7 | Angioneurotic Oedema
on Jul 17, 2006 Female patient from UNITED STATES , 52 years of age, weighting 125.0 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: angioneurotic oedema. Factive dosage: 320 Mf, Qd, Oral.

5210148-X | Swelling Face
on Jul 07, 2006 Male patient from UNITED STATES , 28 years of age, weighting 164.9 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: swelling face. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with EXCEDRIN (MIGRAINE) (View Excedrin (migraine) Review and Excedrin (migraine) Label ).

5210140-5 | Insomnia, Paraesthesia
Patient was taking Factive (View Usage). Patient had the following side effects: insomnia, paraesthesia on Sep 25, 2006 from UNITED STATES Additional patient health information: Male patient , 70 years of age, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral.

5210138-7 | Face Oedema, Vertigo
Adverse event was reported on Sep 08, 2006 by a Male patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with respiratory tract infection bacterial and. Location: UNITED STATES , 44 years of age, weighting 220.0 lb, After Factive was administered, patient had the following side effects: face oedema, vertigo.

5210136-3 | Abdominal Pain Upper, Dry Eye, Dyspnoea, Haematochezia, Swelling Face, Urticaria, Vision Blurred
on Aug 22, 2006 Male patient from UNITED STATES , 62 years of age, weighting 185.0 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain upper, dry eye, dyspnoea, haematochezia, swelling face, urticaria, vision blurred. Factive dosage: 320 Mg, Qd, Oral. During the same period patient was treated with COZAAR (View Cozaar Review and Cozaar Label ), PINDOLOL (View Pindolol Review and Pindolol Label ), DOXAZOSIN (DOXAZOSIN) (View Doxazosin (doxazosin) Review and Doxazosin (doxazosin) Label ), VICODIN (View Vicodin Review and Vicodin Label ).

5210135-1 | Tendonitis
on Aug 11, 2006 Male patient from UNITED STATES , 42 years of age, weighting 179.9 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient had the following side effects: tendonitis. Factive dosage: 320 Mg, Qd, Oral.

5210134-X | Chest Pain, Dyspnoea
Patient was taking Factive (View Usage). After Factive was administered, patient had the following side effects: chest pain (What is chest pain?), dyspnoea on Aug 04, 2006 from UNITED STATES Additional patient health information: Female patient , 76 years of age, weighting 175.0 lb, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral; 160 Mg, Qd,oral. During the same period patient was treated with ASPIRIN (View Aspirin Review and Aspirin Label ), ZETIA (View Zetia Review and Zetia Label ).

5210125-9 | Rash
Adverse event was reported on Aug 16, 2006 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with respiratory tract infection bacterial and. Location: UNITED STATES , 16 years of age, Patient experienced the following unwanted or unexpected effects: rash (What is rash?).

5210122-3 | Fatigue, Nausea
on Aug 15, 2006 Male patient from UNITED STATES , 33 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient had the following side effects: fatigue, nausea (What is nausea?). Factive dosage: 320 Mg, Qd, Oral.

5210121-1 | Rash Macular
on Aug 15, 2006 Male patient from UNITED STATES , 30 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: rash macular. Factive dosage: 320 Mg, Qd, Oral.

5210115-6 | Rash
Patient was taking Factive (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?) on Jul 31, 2006 from UNITED STATES Additional patient health information: Female patient , 23 years of age, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral.

5210108-9 | Dysgeusia, Pain In Extremity
Adverse event was reported on Jul 20, 2006 by a Female patient taking Factive (View Usage) (Dosage: 320 Mg, Qd, Oral) was diagnosed with respiratory tract infection bacterial, sinusitis (What is sinusitis?) and. Location: UNITED STATES , 45 years of age, weighting 100.1 lb, Patient had the following side effects: dysgeusia, pain in extremity. During the same period patient was treated with OMNICEF (300mg, Bid, Oral) (View Omnicef Review and Omnicef Label ), RONDEC DM (CARBINOXAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, PSEUD (View Rondec Dm (carbinoxamine Maleate, Dextromethorphan Hydrobromide, Pseud Review and Rondec Dm (carbinoxamine Maleate, Dextromethorphan Hydrobromide, Pseud Label ).

5210102-8 | Pityriasis Rosea
on Sep 15, 2006 Male patient from UNITED STATES , 47 years of age, weighting 173.1 lb, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). After Factive was administered, patient had the following side effects: pityriasis rosea. Factive dosage: 320 Mg, Qd, Oral.

5210099-0 | Rash
on Sep 13, 2006 Male patient from UNITED STATES , 80 years of age, was diagnosed with respiratory tract infection bacterial and was treated with Factive (View Usage). Patient experienced the following unwanted or unexpected effects: rash (What is rash?). Factive dosage: .

5210096-5 | Rash Erythematous
Patient was taking Factive (View Usage). Patient had the following side effects: rash erythematous on Sep 06, 2006 from UNITED STATES Additional patient health information: Female patient , 25 years of age, was diagnosed with respiratory tract infection bacterial and. Factive dosage: 320 Mg, Qd, Oral.